These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 32671688)

  • 21. SARS-CoV-2/COVID-19: Viral Genomics, Epidemiology, Vaccines, and Therapeutic Interventions.
    Uddin M; Mustafa F; Rizvi TA; Loney T; Suwaidi HA; Al-Marzouqi AHH; Eldin AK; Alsabeeha N; Adrian TE; Stefanini C; Nowotny N; Alsheikh-Ali A; Senok AC
    Viruses; 2020 May; 12(5):. PubMed ID: 32397688
    [TBL] [Abstract][Full Text] [Related]  

  • 22. COVID-19 disrupts vaccine delivery.
    Nelson R
    Lancet Infect Dis; 2020 May; 20(5):546. PubMed ID: 32311326
    [No Abstract]   [Full Text] [Related]  

  • 23. COVID-19: The Need for Immunoprevention at Industrial Scale.
    Halstead SB
    Am J Trop Med Hyg; 2020 Jun; 102(6):1151. PubMed ID: 32274985
    [No Abstract]   [Full Text] [Related]  

  • 24. Rapid and robust bioanalytical assays are critical for SARS-CoV-2 therapeutic and vaccine development and beyond.
    Kar S; Islam R
    Bioanalysis; 2020 Sep; 12(17):1199-1203. PubMed ID: 32453605
    [No Abstract]   [Full Text] [Related]  

  • 25. Development of a Fluorescence-Based, High-Throughput SARS-CoV-2 3CL
    Froggatt HM; Heaton BE; Heaton NS
    J Virol; 2020 Oct; 94(22):. PubMed ID: 32843534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Challenges in evaluating SARS-CoV-2 vaccines during the COVID-19 pandemic.
    Abu-Raya B; Gantt S; Sadarangani M
    CMAJ; 2020 Aug; 192(34):E982-E985. PubMed ID: 32646869
    [No Abstract]   [Full Text] [Related]  

  • 27. COVID-19 pandemic predictions using the modified Bateman SIZ model and observational data for Heidelberg, Germany: Effect of vaccination with a SARS-CoV-2 vaccine, coronavirus testing and application of the Corona-Warn-App.
    Braun P; Haffner S; Woodcock BG
    Int J Clin Pharmacol Ther; 2020 Aug; 58(8):417-425. PubMed ID: 32646540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines.
    Salvatori G; Luberto L; Maffei M; Aurisicchio L; Roscilli G; Palombo F; Marra E
    J Transl Med; 2020 Jun; 18(1):222. PubMed ID: 32493510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Responding to Covid-19 - A Once-in-a-Century Pandemic?
    Gates B
    N Engl J Med; 2020 Apr; 382(18):1677-1679. PubMed ID: 32109012
    [No Abstract]   [Full Text] [Related]  

  • 30. SARS-CoV-2/COVID-19 and advances in developing potential therapeutics and vaccines to counter this emerging pandemic.
    Rabaan AA; Al-Ahmed SH; Sah R; Tiwari R; Yatoo MI; Patel SK; Pathak M; Malik YS; Dhama K; Singh KP; Bonilla-Aldana DK; Haque S; Martinez-Pulgarin DF; Rodriguez-Morales AJ; Leblebicioglu H
    Ann Clin Microbiol Antimicrob; 2020 Sep; 19(1):40. PubMed ID: 32878641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. COVID-19: An overview of the current pharmacological interventions, vaccines, and clinical trials.
    Chakraborty R; Parvez S
    Biochem Pharmacol; 2020 Oct; 180():114184. PubMed ID: 32739342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Towards effective COVID‑19 vaccines: Updates, perspectives and challenges (Review).
    Calina D; Docea AO; Petrakis D; Egorov AM; Ishmukhametov AA; Gabibov AG; Shtilman MI; Kostoff R; Carvalho F; Vinceti M; Spandidos DA; Tsatsakis A
    Int J Mol Med; 2020 Jul; 46(1):3-16. PubMed ID: 32377694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. COVID-19 therapies and vaccine landscape.
    Nat Mater; 2020 Aug; 19(8):809. PubMed ID: 32704138
    [No Abstract]   [Full Text] [Related]  

  • 34. Covid-19 Pandemic: Through the Lens of Science, a Painstaking Review.
    Alsrhani A; Junaid K; Younas S; Hamam SSM; Ejaz H
    Clin Lab; 2020 Oct; 66(10):. PubMed ID: 33073946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The post-lockdown period should be used to acquire effective therapies for future resurgence in SARS-Cov-2 infections.
    Krause KL; Furneaux R; Benjes P; Brimble M; Davidson T; Denny W; Harris L; Hinkley S; Tyler P; Ussher JE; Ward V
    N Z Med J; 2020 Apr; 133(1513):107-111. PubMed ID: 32325475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advances in the possible treatment of COVID-19: A review.
    Chibber P; Haq SA; Ahmed I; Andrabi NI; Singh G
    Eur J Pharmacol; 2020 Sep; 883():173372. PubMed ID: 32682787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Covid-19: Should doctors recommend treatments and vaccines when full data are not publicly available?
    Johnson RM; Doshi P; Healy D
    BMJ; 2020 Aug; 370():m3260. PubMed ID: 32839164
    [No Abstract]   [Full Text] [Related]  

  • 38. A review of potential treatments to date in COVID-19 patients according to the stage of the disease.
    Alsuliman T; Alasadi L; Alkharat B; Srour M; Alrstom A
    Curr Res Transl Med; 2020 Aug; 68(3):93-104. PubMed ID: 32540367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimizing use of theranostic nanoparticles as a life-saving strategy for treating COVID-19 patients.
    Itani R; Tobaiqy M; Al Faraj A
    Theranostics; 2020; 10(13):5932-5942. PubMed ID: 32483428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fighting COVID-19.
    Campos DMO; Oliveira CBS; Andrade JMA; Oliveira JIN
    Braz J Biol; 2020 Sep; 80(3):698-701. PubMed ID: 32555974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.